

Hair Loss Treatments in Clinical Trials: PP405 and ET-02
2025 brings revolutionary hair loss treatments: UCLA’s PP405 molecule shows 31% hair density increase in trials, while ET-02 outperforms minoxidil 6x faster. Discover the latest breakthroughs, clinical trials, and FDA-approved therapies transforming hair restoration.



